Related Experiment Videos
[Erythromycin pharmacokinetics in children after rectal and oral administration]
Insights
New enteric-coated erythromycin tablets and suppositories show significantly higher bioavailability in children. Absorption increases with age, especially for rectal suppositories, improving antibiotic effectiveness.
Area of Science:
- Pediatrics
- Pharmacology
- Clinical Pharmacy
Background:
- Erythromycin is a widely used antibiotic in pediatric populations.
- Optimizing antibiotic delivery and absorption in children is crucial for effective treatment.
- Existing erythromycin formulations may have variable bioavailability in pediatric patients.
Purpose of the Study:
- To evaluate the pharmacokinetics of new pediatric dosage forms of erythromycin base.
- To compare the bioavailability of enteric-coated tablets and suppositories against uncoated tablets.
- To assess the influence of age on erythromycin absorption in children.
Main Methods:
- Clinical pharmacokinetic study in children up to 14 years old.
- Administration of new pediatric dosage forms: 0.1g and 0.25g enteric-coated tablets, 0.06g and 0.125g suppositories.
- Comparison of bioavailability with standard erythromycin base tablets without coating.
Main Results:
- New enteric-coated erythromycin dosage forms demonstrated 2.5-3 times higher bioavailability than uncoated tablets.
- Rectal suppository absorption showed a systematic increase with advancing child age.
- Absolute absorption rates were 28% in newborns, 36% in sucklings, and 54% in children over 1 year.
Conclusions:
- Enteric-coated erythromycin tablets and suppositories offer superior bioavailability in pediatric patients.
- Age-dependent absorption of rectal erythromycin suppositories suggests optimized dosing strategies for different pediatric age groups.
- These new formulations represent an advancement in pediatric antibiotic therapy, potentially improving treatment outcomes.
Abstract:
Pharmacokinetics of erythromycin base was studied clinically in children not older than 14 years treated with new children dosage forms of the antibiotic i. e. 0.1 and 0.25 g enteric coated tablets and 0.06 and 0.125 g suppositories. It was noted that the new dosage forms were characterized by higher availability which was 2.5-3 times higher than that after using the erythromycin base tablets without the coating. Systematic increasing of erythromycin availability after the use of the rectal suppositories was observed with increasing of the children age. Absolute absorption in newborns, sucklings and children over 1 year amounted to 28, 36 and 54 per cent respectively.